Evidence map›Paper›PMID 24872578›Full record

ArticleJournal of virology2014

Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.

Hisashi Akiyama, Caitlin Miller, Hiren V Patel, Steven C Hatch, Jacob Archer, Nora-Guadalupe P Ramirez, Suryaram Gummuluru

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Pseudotyped Virus for Henipavirus.Advances in experimental medicine and biology · 2023
    Review
  6. Article
  7. Article
  8. Virus-Mimicking Polymer Nanoparticles Targeting CD169ACS applied materials & interfaces · 2022
    Article
  9. HIV-1Pathogens (Basel, Switzerland) · 2021
    Review
  10. Review
  11. Article
  12. CD169 Defines Activated CD14Frontiers in immunology · 2021
    Article
  13. Dissemination ofJournal of extracellular vesicles · 2021
    Article
  14. Article
  15. Article
  16. Selective tumor antigen vaccine delivery to human CD169Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Review
  18. Siglecs at the Host-Pathogen Interface.Advances in experimental medicine and biology · 2020
    Review
  19. Review
  20. Membrane-wrapped nanoparticles probe divergent roles of GM3 and phosphatidylserine in lipid-mediated viral entry pathways.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hisashi AkiyamaDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Caitlin MillerDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Hiren V PatelDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Steven C HatchDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Jacob ArcherDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Nora-Guadalupe P RamirezDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Suryaram GummuluruDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA rgummulu@bu.edu.
Boston University · US

Funding

RESEARCH TRAINING IN IMMUNOLOGYT32AI007309 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM · 1988 to 2024
$7.4M
Mechanism of cell-associated HIV-1 transmissionR01AI064099 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM · 2005 to 2020
$5.9M
Mechanism of HIV-1 attachment to dendritic cellsR21AI081596 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM · 2009 to 2010
$445k
NIAID NIH HHS 5T32AI007309-23NIAID NIH HHS AI064099NIAID NIH HHS R01 AI064099NIAID NIH HHS R21 AI081596NIAID NIH HHS T32 AI007309
6 · The paper itself

Abstract

unlabelledHuman immunodeficiency virus type 1 (HIV-1) exploits dendritic cells (DCs) to promote its transmission to T cells. We recently reported that the capture of HIV-1 by mature dendritic cells (MDCs) is mediated by an interaction between the glycosphingolipid (GSL) GM3 on virus particles and CD169/Siglec-1 on MDCs. Since HIV-1 preferentially buds from GSL-enriched lipid microdomains on the plasma membrane, we hypothesized that the virus assembly and budding site determines the ability of HIV-1 to interact with MDCs. In support of this hypothesis, mutations in the N-terminal basic domain (29/31KE) or deletion of the membrane-targeting domain of the HIV-1 matrix (MA) protein that altered the virus assembly and budding site to CD63(+)/Lamp-1-positive intracellular compartments resulted in lower levels of virion incorporation of GM3 and attenuation of virus capture by MDCs. Furthermore, MDC-mediated capture and transmission of MA mutant viruses to T cells were decreased, suggesting that HIV-1 acquires GSLs via budding from the plasma membrane to access the MDC-dependent trans infection pathway. Interestingly, MDC-mediated capture of Nipah and Hendra virus (recently emerged zoonotic paramyxoviruses) M (matrix) protein-derived virus-like particles that bud from GSL-enriched plasma membrane microdomains was also dependent on interactions between virion-incorporated GSLs and CD169. Moreover, capture and transfer of Nipah virus envelope glycoprotein-pseudotyped lentivirus particles by MDCs were severely attenuated upon depletion of GSLs from virus particles. These results suggest that GSL incorporation into virions is critical for the interaction of diverse enveloped RNA viruses with DCs and that the GSL-CD169 recognition nexus might be a conserved viral mechanism of parasitization of DC functions for systemic virus dissemination. IMPORTANCE: Dendritic cells (DCs) can capture HIV-1 particles and transfer captured virus particles to T cells without establishing productive infection in DCs, a mechanism of HIV-1 trans infection. We have recently identified CD169-mediated recognition of GM3, a host-derived glycosphingolipid (GSL) incorporated into the virus particle membrane, as the receptor and ligand for the DC-HIV trans infection pathway. In this study, we have identified the matrix (MA) domain of Gag to be the viral determinant that governs incorporation of GM3 into HIV-1 particles, a previously unappreciated function of the HIV-1 MA. In addition, we demonstrate that the GSL-CD169-dependent trans infection pathway is also utilized as a dissemination mechanism by henipaviruses. GSL incorporation in henipaviruses was also dependent on the viral capsid (M) protein-directed assembly and budding from GSL-enriched lipid microdomains. These findings provide evidence of a conserved mechanism of retrovirus and henipavirus parasitization of cell-to-cell recognition pathways for systemic virus dissemination.

Indexed as

Cell LineDendritic Cellsgag Gene Products, Human Immunodeficiency VirusGlycosphingolipidsHenipavirusHenipavirus InfectionsHIV-1HIV InfectionsHumansMembrane MicrodomainsSialic Acid Binding Ig-like Lectin 1VirionVirus AssemblyVirus Releasegag Gene Products, Human Immunodeficiency VirusGlycosphingolipidsSialic Acid Binding Ig-like Lectin 1SIGLEC1 protein, human

Identifiers

PMID24872578
PMCPMC4136256
OpenAlexW2044425027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.